Referencias bibliográficas

  1. García-Collinot, Grettel et al. “Effectiveness of Saccharomyces boulardii and Metronidazole for Small Intestinal Bacterial Overgrowth in Systemic Sclerosis.” Digestive diseases and sciences vol. 65,4 (2020): 1134-1143. doi:10.1007/s10620-019-05830-0
  2. Ghoshal, Uday C., et al. “Small intestinal bacterial overgrowth: a clinical review.” Journal of gastroenterology 55.8 (2020): 801-815.
  3. Leite, Gabriela et al. “Defining Small Intestinal Bacterial Overgrowth by Culture and High Throughput Sequencing.” Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association vol. 22,2 (2024): 259-270. doi:10.1016/j.cgh.2023.06.001
  4. Patangia, Dhrati V et al. “Impact of antibiotics on the human microbiome and consequences for host health.” MicrobiologyOpen vol. 11,1 (2022): e1260. doi:10.1002/mbo3.1260
  5. Quigley, Eamonn M M, and Rodrigo Quera. “Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics.” Gastroenterology vol. 130,2 Suppl 1 (2006): S78-90. doi:10.1053/j.gastro.2005.11.046
  6. Rezaie, Ali et al. “Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus.” The American journal of gastroenterology vol. 112,5 (2017): 775-784. doi:10.1038/ajg.2017.46
  7. Shah, Ayesha et al. “Links between celiac disease and small intestinal bacterial overgrowth: A systematic review and meta-analysis.” Journal of gastroenterology and hepatology vol. 37,10 (2022): 1844-1852. doi:10.1111/jgh.15920
  8. Zhong, Changqing et al. “Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analysis and Systematic Review of Current Evidence.” Journal of clinical gastroenterology vol. 51,4 (2017): 300-311. doi:10.1097/MCG.0000000000000814